91.7 Ann Arbor/Detroit 104.1 Grand Rapids 91.3 Port Huron 89.7 Lansing 91.1 Flint
Play Live Radio
Next Up:
0:00 0:00
Available On Air Stations

Fauci To Appear Before Senate Panel, But Not 'Trump Haters' In The House, Trump Says

Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, and CDC Director Robert Redfield will appear before a Senate committee on May 12.
Patrick Semansky
Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, and CDC Director Robert Redfield will appear before a Senate committee on May 12.

Dr. Anthony Fauci, the director of the National Institute of Allergy and Infectious Diseases, will join Centers for Disease Control and Prevention Director Robert Redfield and other administration representatives in testifying before a Senate committee on May 12.

The announcement comes as members of President Trump's coronavirus task force are being asked to limit their appearances on Capitol Hill despite ongoing calls from lawmakers for more oversight into the administration's coronavirus response. Last week, the Trump administration blocked Fauci from appearing before a House committee on the subject of spending on coronavirus testing.

President Trump told reporters Tuesday that he doesn't want the officials appearing before House Democrats.

"The House is a setup," Trump said. "The House is a bunch of Trump haters."

White House officials gave a less adversarial explanation when justifying the decision to limit task force testimony in a memo to top congressional aides.

"For primary response departments, including HHS, DHS, and State, in order to preserve department-wide resources, no more than one COVID-related hearing should be agreed to with the department's primary House and Senate authorizing committee and appropriations subcommittee in the month of May, for a total of no more than four COVID-related hearings department-wide," the memo stated.

Congressional Democrats are demanding greater oversight over the roughly $3 trillion that has already been approved for the coronavirus response. House Speaker Nancy Pelosi, D-Calif., has launched a new select committee to conduct the oversight, but Republicans have so far refused to name members to the panel despite the plan to make the panel bipartisan.

The Senate hearing was announced shortly after the administration sent the memo to Capitol Hill banning committee appearances from task force members during May unless approved by the White House chief of staff.

Deputy White House Press Secretary Judd Deere said the decision to block Fauci from the House committee appearance was intended to allow him to focus on his primary task of overseeing the coronavirus response.

"While the Trump Administration continues its whole-of-government response to COVID-19, including safely opening up America again and expediting vaccine development, it is counter-productive to have the very individuals involved in those efforts appearing at Congressional hearings," Deere said. "We are committed to working with Congress to offer testimony at the appropriate time."

Fauci, Redfield, HHS Assistant Secretary Brett Giroir and FDA Commissioner Stephen Hahn are scheduled to discuss "safely getting back to work and back to school" when they appear before the Health, Education, Labor and Pensions — or HELP — Committee next Tuesday.

Senate Democrats, including Patty Murray, D-Wash., the top Democrat on the HELP committee, have called for the administration to provide greater transparency and a nationwide plan for testing. So far their demands have not received a response.

Copyright 2021 NPR. To see more, visit https://www.npr.org.

Kelsey Snell is a Congressional correspondent for NPR. She has covered Congress since 2010 for outlets including The Washington Post, Politico and National Journal. She has covered elections and Congress with a reporting specialty in budget, tax and economic policy. She has a graduate degree in journalism from the Medill School of Journalism at Northwestern University in Evanston, Ill. and an undergraduate degree in political science from DePaul University in Chicago.